Market Cap

Oxford Biomedica plc Market Capitalization:

£349.6 Million

GBP as of July 1, 2024

US$442.2 Million

business Oxford Biomedica plc Company Profile

Oxford Biomedica plc Main Stock Listing

LSE: OXB

Market Capitalization History of Oxford Biomedica plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Oxford Biomedica plc market cap

Date Market Cap YoY Change
Jan. 1, 2024 £213.0 M -50.62%
Jan. 1, 2023 £431.3 M -47.04%
Jan. 1, 2022 £814.3 M -13.97%
Jan. 1, 2021 £946.5 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Oxford Biomedica plc Categories

United Kingdom languages Healthcare languages Biotechnology
United Kingdom Healthcare United Kingdom Biotechnology

Stocks & Indices

Oxford Biomedica plc has the following listings and related stock indices.


Stock: LSE: OXB

Stock: FSX: OXOA

Stock: OTC: OXBDF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.